Immune response in COVID-19: what is next?

Q Li, Y Wang, Q Sun, J Knopf, M Herrmann… - Cell Death & …, 2022‏ - nature.com
Abstract The coronavirus disease 2019 (COVID-19) has been a global pandemic for more
than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A …

A long way to go: caspase inhibitors in clinical use

S Dhani, Y Zhao, B Zhivotovsky - Cell death & disease, 2021‏ - nature.com
Caspases are an evolutionary conserved family of cysteine-dependent proteases that are
involved in many vital cellular processes including apoptosis, proliferation, differentiation …

T cell apoptosis characterizes severe Covid-19 disease

S André, M Picard, R Cezar, F Roux-Dalvai… - Cell Death & …, 2022‏ - nature.com
Severe SARS-CoV-2 infections are characterized by lymphopenia, but the mechanisms
involved are still elusive. Based on our knowledge of HIV pathophysiology, we hypothesized …

NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1–infected patients

C Zhang, JW Song, HH Huang, X Fan, L Huang… - The Journal of clinical …, 2021‏ - jci.org
Chronic HIV-1 infection is generally characterized by progressive CD4+ T cell depletion due
to direct and bystander death that is closely associated with persistent HIV-1 replication and …

Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response

A Santa Cruz, A Mendes-Frias… - Nature …, 2023‏ - nature.com
Several millions of individuals are estimated to develop post-acute sequelae SARS-CoV-2
condition (PASC) that persists for months after infection. Here we evaluate the immune …

Role of cytokines in experimental and human visceral leishmaniasis

M Samant, U Sahu, SC Pandey… - Frontiers in cellular and …, 2021‏ - frontiersin.org
Visceral Leishmaniasis (VL) is the most fatal form of disease leishmaniasis. To date, there
are no effective prophylactic measures and therapeutics available against VL. Recently, new …

Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV

GH Mylvaganam, LS Chea, GK Tharp, S Hicks… - JCI …, 2018‏ - pmc.ncbi.nlm.nih.gov
Therapeutic strategies that augment antiviral immunity and reduce the viral reservoir are
critical to achieving durable remission of HIV. The coinhibitory receptor programmed death-1 …

The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection

Q Le Hingrat, I Sereti, AL Landay, I Pandrea… - Frontiers in …, 2021‏ - frontiersin.org
CD4+ T-cell depletion is pathognomonic for AIDS in both HIV and simian immunodeficiency
virus (SIV) infections. It occurs early, is massive at mucosal sites, and is not entirely reverted …

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease

JC Milligan, TU Zeisner, G Papageorgiou… - Biochemical …, 2021‏ - portlandpress.com
The coronavirus 2019 (COVID-19) pandemic, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), spread around the world with unprecedented …

Caspase family in autoimmune diseases

W Zhang, H Wu, Y Liao, C Zhu, Z Zou - Autoimmunity Reviews, 2024‏ - Elsevier
Programmed cell death (PCD) plays a crucial role in maintaining tissue homeostasis, with its
primary forms including apoptosis, pyroptosis, and necroptosis. The caspase family is …